oral glp 1 tirzepatide GLP-1 for Weight Loss: What You Need to Know GLP-1 agonist tirzepatide and oral

Cellular and Molecular Biology (Noisy-le-Grand, France) 2004;50:OL543OL551

Its digital-first model appeals to patients who prefer managing healthcare from home

7 The mechanisms of action involve delaying gastric emptying, reducing appetite, and improving insulin sensitivity, thereby helping individuals consume fewer calories

A year later, the brand went fully mainstream by hitting Target shelves across the US, followed by a January 2026 launch in Walmart stores nationwide

The SURMOUNT-4 trial demonstrated that patients who discontinued tirzepatide after achieving significant weight loss regained approximately two-thirds of lost weight within one year

The 2026 pilot program expands coverage to a specific subset of patients with obesity and qualifying comorbidities